HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Over 15 years' experience in both finance and healthcare, covering clinic operations, investment and equity research in both China and overseas.

CStone Pharmaceuticals Placement (2616.HK) - There Is No Certainty that the Dilemma Will Reverse

China Healthcare Weekly (Feb.10) - Assisted Reproduction into NRDL, Cell Therapy, Medicilon, IRay,

Jacobio Pharmaceuticals Placement (1167.HK) - We Keep Hope for Jacobio Because of Dr. Wang Yinxiang

China Healthcare Weekly (Feb.3)- CanSino, Blood Products Shortage, Don't Be Greedy in Front of Rally

China Shineway Pharmaceutical (2877.HK) - Some Points Worth the Attention

Alphamab Co Ltd Placement (9966.HK) - Has No Potential to Be a Biopharma; Just Remain as a Biotech

China Traditional Chinese Medicine (570.HK) - The Privatization Rumor and the Outlook

Thematic (Sector/Industry)

Japan Healthcare equipment and services / Thematic (Sector/Industry)

<ul>
<li>Since the US and China could not agree beforehand, it would be useless for Antony Blinken to come. Or only discuss the balloon?</li>
<li>Many people are worried about the escalation of Sino-US confrontation. The key to the occurrence of the Taiwan Strait War is who will become the new president of the US.</li>
<li>The three crises of the US dollar in the past 50 years have been redeemed by war, including "various forms of war".Perhaps, we should get ready for a new era. </li>
</ul>


Since the US and China could not agree beforehand, it would be useless for Antony Blinken to come. Or only discuss the balloon?
Many people are worried about the escalation of Sino-US confrontation. The key to the occurrence of the Taiwan Strait War is who will become the new president of the US.
The three crises of the US dollar in the past 50 years have been redeemed by war, including "various forms of war".Perhaps, we should get ready for a new era. 


Antony Blinken, Balloon, China, Adani, Russia, Taiwan, Fed, US Dollar - We Didn’t Start the Fire